IPO registrations (S-1, F-1) · Registrants
NeuroPace Inc
- SEC CIK
- 1528287 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-03-24, last 2021-04-14; 1 initial registration, 1 amendment
- Outcome
- Final prospectus filed 2021-04-23; declared effective 2021-04-20
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 455 N. BERNARDO AVENUE, Mountain View, CA 94043
- EIN
- 22-3550230
- Ticker
- NPCE (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- NeuroPace Inc on the corporate pages
Offering terms
- Proposed price range
- $15.00–$17.00 per share (S-1/A filed 2021-04-14)
- Final price
- $17.00 per share, within the range (424B4 filed 2021-04-23, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $102,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NPCE
- Lead underwriters
- J.P. Morgan (2,250,000 shares); Morgan Stanley (2,250,000 shares)
- Syndicate
- Wells Fargo (840,000); Leerink Partners (660,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: NEUROPACE, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: NeuroPace, Inc. Fuzzy (name and state)
- Business registration: NeuroPace, Inc. Fuzzy (name and state)
- Business registration: NeuroPace, Inc. Fuzzy (name and state)
- Business registration: NEUROPACE, Inc. Fuzzy (name and state)
- Business registration: NEUROPACE, INC. Fuzzy (name and state)
- Business registration: NEUROPACE, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: NEUROPACE, INC. EXACT (EIN (EXACT))
- Federal award recipient: NEUROPACE INC Fuzzy (name and state)
- Form D issuer: NeuroPace Inc EXACT (CIK (EXACT))
- Lobbying client: NEUROPACE, INC. Fuzzy (name and state)
- SEC filer: NeuroPace Inc EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-03-24 | S-1 | S-1 (registration) | NeuroPace Inc | 0001628280-21-005481 ↗ |
| 2021-04-14 | S-1/A | S-1/A (amendment) | NeuroPace Inc | 0001628280-21-006852 ↗ |
| 2021-04-20 | EFFECT | EFFECT (declared effective) | NeuroPace Inc | 9999999995-21-001509 ↗ |
| 2021-04-21 | S-1MEF | S-1MEF (added securities) | NeuroPace Inc | 0001628280-21-007308 ↗ |
| 2021-04-21 | EFFECT | EFFECT (declared effective) | NeuroPace Inc | 9999999995-21-001527 ↗ |
| 2021-04-23 | 424B4 | 424B4 (final prospectus) | NeuroPace Inc | 0001628280-21-007414 ↗ |
| 2022-11-22 | EFFECT | EFFECT (declared effective) | NeuroPace Inc | 9999999995-22-003379 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-04-14 | S-1/A | registration statement | $15.00–$17.00 | 5,313,000 | - | Nasdaq NPCE | 2 | primary document; range, shares headline | document ↗ | |
| 2021-04-23 | 424B4 | final prospectus | $17.00 | 6,000,000 | $102,000,000 | Nasdaq NPCE | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Accelmed Partners II L.P. | TenPercentOwner | 4 | 2021–2022 | ||
| Favet Michael | Director,Officer | Chief Executive Officer | 6 | 2021–2023 | |
| Fischer Frank M | Director | 13 | 2021–2026 | ||
| Garfield Greg Shaw | Director | 4 | 2021–2022 | ||
| KCK LTD. | TenPercentOwner | 10 | 2021–2025 | ||
| Kuhn Rebecca | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 15 | 2021–2025 | |
| Kumar Rakhi | Director | 12 | 2021–2026 | ||
| LACOB JOSEPH | Director | 12 | 2021–2026 | ||
| Morrell Martha | Officer | Chief Medical officer; Chief Medical Officer; CHIEF MEDICAL OFFICER | 40 | 2021–2026 | |
| Norton Evan | Director | 4 | 2021 | ||
| ORBIMED ADVISORS LLC | TenPercentOwner | 10 | 2021–2025 | ||
| OrbiMed Capital GP VI LLC | TenPercentOwner | 10 | 2021–2025 | ||
| Ridley Irina | Officer | Chief Legal Officer/Secretary; General Counsel and Secretary | 8 | 2021–2023 | |
| Ryan Renee | Director | 7 | 2021–2026 | ||
| Andrade Lisa | Director | 7 | 2021–2026 | ||
| Geiger Uri | Director | 11 | 2023–2026 | ||
| Becker Joel | Director,Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 14 | 2023–2026 | |
| Huennekens R Scott | Director | 4 | 2025–2026 | ||
| Williams Patrick F. | Officer | Chief Financial Officer | 4 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-08-31 | NeuroPace Inc | Other Health Care | $96,385,618 | $69,385,618 | 23 | 1 |
| 2017-01-09 | NeuroPace Inc | Other Health Care | $80,000,001 | $72,000,001 | 26 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | NeuroPace, Inc. | CA | State business registries | name and state |
| Business registration | NeuroPace, Inc. | CA | State business registries | name and state |
| Business registration | NeuroPace, Inc. | CA | State business registries | name and state |
| Business registration | NEUROPACE, Inc. | CA | State business registries | name and state |
| Business registration | NEUROPACE, INC. | CA | State business registries | name and state |
| Business registration | NEUROPACE, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | NEUROPACE, INC. | CA | State business registries | name and state |
| Federal award recipient | NEUROPACE INC | CA | Federal spending (USAspending) | name and state |
| Form D issuer | NeuroPace Inc | CA | Form D private offerings | CIK (EXACT) |
| IPO registrant | TELESENSORY CORP | CA | IPO registrations (S-1, F-1) | same street address and ZIP code, 455 N BERNARDO AVE 94043 (FUZZY: a shared address, not proof of a shared organization) |
| Lobbying client | NEUROPACE, INC. | CA | Federal lobbying (LDA) | name and state |
| Paying company | NEUROPACE, INC. | CA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | NeuroPace, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | NeuroPace Inc | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | NeuroPace, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | NEUROPACE, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, CA first:
- FUSION MEDICAL TECHNOLOGIES INC CA
- ENDOLOGIX INC /DE/ CA
- CEMAX ICON INC CA
- TRYLON CORP CA
- R2 TECHNOLOGY INC CA
- CERUS CORP CA
- SOMNUS MEDICAL TECHNOLOGIES INC CA
- MICRUS ENDOVASCULAR CORP CA
- AEROGEN INC CA
- IOMED LLC CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology